Dr. Maria Lindgren, Ph.D.

Head of Clinical Development

Dr. Maria Lindgren is Head of Clinical Development and managing the IP strategy at Sigrid Therapeutics AB. She has more than 15 years’ experience in biotech drug development companies, with deliveries within CMC, nonclinical to phase II clinical trials.

Dr. Maria has experience from research and development in a wide variety of projects, from peptide and nucleotide delivery, cancer resistance and hematology indications such as sickle cell disease. She is motivated by leading successful cross-functional teams of international academic scientists, innovators and developers. Dr. Maria is devoted to finding ways to bring forward new treatments from scientific research into commercialization.

Dr. Maria Lindgren received her Ph.D. in Neurochemistry from Stockholm University.